Literature DB >> 6861078

Time trend in the prevalence of intestinal metaplasia in Japan.

T Imai, H Murayama.   

Abstract

In connection with the recently commenced decline of death rate for gastric cancer in Japan, the time trend of intestinal metaplasia of the stomach among the Japanese is investigated. Otherwise normal stomachs from autopsies, and stomachs removed for gastric or duodenal ulcer or for early gastric carcinoma, each collected from two different periods at intervals of 10 to 20 years, are compared histologically. The results show that the prevalence of intestinal metaplasia in those stomachs generally remains high, but that there is a regular downward tendency of the prevalence of confluent intestinal metaplasia in all of those stomachs, except for the stomachs with gastric ulcer. The fall in prevalence is conspicuous among the individuals of middle age groups, especially of patients aged in their 40s, and it is minimized toward old age. The decrease of intestinal metaplasia among the Japanese is considered to have been started only recently. There is no evidence verifying the antecedence of the fall in prevalence of intestinal metaplasia to the decline of death rate for gastric cancer in Japan. Evidence does not suggest a precancerous nature of intestinal metaplasia per se.

Entities:  

Mesh:

Year:  1983        PMID: 6861078     DOI: 10.1002/1097-0142(19830715)52:2<353::aid-cncr2820520229>3.0.co;2-3

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  Time Trends in Helicobacter pylori Infection and Atrophic Gastritis Over 40 Years in Japan.

Authors:  Tomoari Kamada; Ken Haruma; Masanori Ito; Kazuhiko Inoue; Noriaki Manabe; Hiroshi Matsumoto; Hiroaki Kusunoki; Jiro Hata; Masaharu Yoshihara; Koji Sumii; Takashi Akiyama; Shinji Tanaka; Akiko Shiotani; David Y Graham
Journal:  Helicobacter       Date:  2015-01-07       Impact factor: 5.753

2.  Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres.

Authors:  M I Filipe; F Potet; W V Bogomoletz; P A Dawson; B Fabiani; P Chauveinc; A Fenzy; B Gazzard; D Goldfain; R Zeegen
Journal:  Gut       Date:  1985-12       Impact factor: 23.059

3.  Histopathogenesis of intestinal metaplasia: minute lesions of intestinal metaplasia in ulcerated stomachs.

Authors:  K Mukawa; T Nakamura; G Nakano; Y Nagamachi
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

4.  Method to quantitate intestinal metaplasia of stomach by image analysis.

Authors:  C A Rubio; A Porwit; M Rodensjö
Journal:  J Clin Pathol       Date:  1988-07       Impact factor: 3.411

Review 5.  Pathophysiological effects of long-term acid suppression in man.

Authors:  R F McCloy; R Arnold; K D Bardhan; D Cattan; E Klinkenberg-Knol; P N Maton; R H Riddell; P Sipponen; A Walan
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

6.  Reciprocal impact of host factors and Helicobacter pylori genotypes on gastric diseases.

Authors:  Sahar Honarmand-Jahromy; Farideh Siavoshi; Reza Malekzadeh; Taher Nejad Sattari; Saeid Latifi-Navid
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

7.  Limited value of type III intestinal metaplasia in predicting risk of gastric carcinoma.

Authors:  K C Ramesar; D S Sanders; D Hopwood
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

8.  Prevalence of subtypes of intestinal metaplasia in gastric antral mucosa.

Authors:  M E Craanen; P Blok; W Dekker; J Ferwerda; G N Tytgat
Journal:  Dig Dis Sci       Date:  1991-11       Impact factor: 3.199

9.  Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum.

Authors:  M E Craanen; W Dekker; P Blok; J Ferwerda; G N Tytgat
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

Review 10.  Gastric Cancer: an Evolving Disease.

Authors:  Minkyo Song; Charles S Rabkin; M Constanza Camargo
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.